Skip to main content

Rivals emerge to Ozempic and Zepbound—but with a lag

By The Wall Street Journal  
   July 19, 2024

Big pharma challengers such as Roche and Amgen could grab a slice of the obesity market.

Full story


Get the latest on healthcare leadership in your inbox.